Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type: Fact Sheets

Filter Results By

Filter Applied. Clear All

Latest Posts

June 13, 2025 Inducing Demand for Abortion in the Absence of Medical Necessity: Planned Parenthood and Abortion Drugs Inducing Demand for Abortion in the Absence of Medical Necessity: Planned Parenthood and Abortion Drugs June 12, 2025 New Peer-Reviewed Article: Planned Parenthood, Abortion Drugs Major Drivers of U.S. Abortions New Peer-Reviewed Article: Planned Parenthood, Abortion Drugs Major Drivers of U.S. Abortions June 10, 2025 Alternatives to In Vitro Fertilization (IVF) for Overcoming Infertility and Delivering a Healthy Baby Alternatives to In Vitro Fertilization (IVF) for Overcoming Infertility and Delivering a Healthy Baby
Reset All Filters
Maternal & Public Health

Fact Sheet: Planned Parenthood’s 2022-23 Annual Report

In April 2024, Planned Parenthood released its annual report for 2022-2023. In this fact sheet, data from that report is summarized.

Maternal & Public Health

Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data

The FDA’s abortion drugs complications data is woefully incomplete. From 2020-2022, the six states that report complications by type of procedure reported 1,004 total complications from drug-induced abortions. Meanwhile, the FDA Adverse Event Reporting System data reflects just 17 unduplicated abortion-related adverse events over this same period.

Maternal & Public Health

Five Facts About “Life-Limiting” Fetal Conditions

Babies prenatally diagnosed with a life-limiting condition often face discrimination. Some continue to refer to these conditions as “lethal” or “fatal” or “incompatible with life.” In such cases abortion is often offered as the only option to families. The fact is, however, that some of these babies may require very minimal medical support after birth or may benefit and be stabilized for further evaluation with medical interventions routinely performed on babies without lethal labels.

Maternal & Public Health

Fact Sheet: A Summary of the CDC’s 2021 Abortion Surveillance Report

There were 625,918 total abortions reported in 2021.

Abortion Drugs

Hoja Informativa: Riesgos y Complicaciones del Aborto QuĂ­mico

El aborto químico tiene una tasa de complicaciones cuatro veces mayor que el aborto quirúrgico, y hasta una de cada cinco mujeres sufrirá una complicación.

Maternal & Public Health

Fact Sheet: Miscarriage Management with Mifepristone

If mifepristone is unavailable, patients will not suffer, for there are several other effective options available for treating a miscarriage. Fearmongering about an inability to treat miscarriages in the aftermath of Dobbs should be recognized for the ideologically driven, pro-abortion rhetoric that it is.

Fact Sheet: Opill, the First Over-the-Counter Hormonal Contraception
Maternal & Public Health

Fact Sheet: Opill, the First Over-the-Counter Hormonal Contraception

Opill, the first nonprescription oral contraceptive pill (OCP) to be granted FDA approval, is a synthetic progesterone (norgestrel) 0.075 mg tablet taken daily (with no placebo week). The following are important facts for women and physicians to know as Opill hits the market for the first time in 2024.

Maternal & Public Health

Fact Sheet: Out-of-State Abortion Complications

Abortion providers often abandon women who suffer complications from their procedures to be treated by other facilities.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image